Terapia prechirurgica della fibromatosi uterina - FedOA - Università ...

proliferation and apoptosis of human uterine leiomyoma. Oncology
1999;57(suppl 2):49-58
80. Khurana KK, Singh SB, Tatum AH, Schulz V, Badawy SZ.
Maintenance of increased Bcl-2 expression in uterine leiomyomas after
GnRH agonist therapy. J Reprod Med 1999;44(6):487-92
81. Valdivia I, Campodónico I, Tapia A, Capetillo M, Espinoza A, Lavin
P. Effects of tibolone and continuous combined hormone therapy on
mammographic breast density and breast histochemical markers in
postmenopausal women. Fertil Steril 2004;81(3):617-23
82. Gompel A, Siromachkova M, Lombet A, Kloosterboer HJ, Rostène
W. Tibolone actions on normal and breast cancer cells. Eur J Cancer
2000;36(suppl 4):S76-S77
83. Gökaslan H, Öktem Ö, Durmuşoğlu F, Eren F. Apoptosis in the
endometrium of postmenopausal women receiving tibolone. Gynecol
Obstet Invest 2003;56:124-7
84. Gregoriou O, Vitoratos N, Papadias C, et al. A. Effect of tibolone on
postmenopausal women with myomas. Maturitas 1997;27:187-91
130